tiprankstipranks
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX

Royalty Pharma (RPRX) Technical Analysis

786 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Royalty Pharma PLC’s (RPRX) Moving Averages Convergence Divergence (MACD) indicator is 0.24, suggesting Royalty Pharma PLC is a Sell.
Royalty Pharma PLC’s (RPRX) 20-Day exponential moving average is 26.98, while Royalty Pharma PLC’s (RPRX) share price is $28.14, making it a Buy.
Royalty Pharma PLC’s (RPRX) 50-Day exponential moving average is 27.12, while Royalty Pharma PLC’s (RPRX) share price is $28.14, making it a Buy.

Royalty Pharma (RPRX) Pivot Points

Jul 22, 2024, 06:42 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
27.05
27.46
27.90
28.31
28.75
29.16
29.60
Fibonacci
27.46
27.79
27.99
28.31
28.64
28.84
29.16
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Royalty Pharma (RPRX) Moving Averages

Jul 22, 2024, 06:42 PM
Period
Simple
Exponential
MA5
27.78Buy
27.79Buy
MA10
26.95Buy
27.30Buy
MA20
26.68Buy
26.98Buy
MA50
26.99Buy
27.12Buy
MA100
28.02Buy
27.55Buy
MA200
27.82Buy
27.73Buy
Royalty Pharma PLC’s (RPRX) 10-Day exponential moving average is 27.30, while Royalty Pharma PLC’s (RPRX) share price is $28.14, making it a Buy.
Royalty Pharma PLC’s (RPRX) 100-Day exponential moving average is 27.55, while Royalty Pharma PLC’s (RPRX) share price is $28.14, making it a Buy.
Royalty Pharma PLC’s (RPRX) stock price is $28.14 and Royalty Pharma PLC’s (RPRX) 50-day simple moving average is 26.99, creating a Buy signal.
Royalty Pharma PLC’s (RPRX) stock price is $28.14 and Royalty Pharma PLC’s (RPRX) 100-day simple moving average is 28.02, creating a Buy signal.
Royalty Pharma PLC’s (RPRX) stock price is $28.14 and Royalty Pharma PLC’s (RPRX) 200-day simple moving average is 27.82, creating a Buy signal.

Royalty Pharma (RPRX) Technical Indicators

Jul 22, 2024, 06:42 PM
Name
Value
Implied Action
RSI (14)
65.97
Neutral
STOCH (9,6)
90.37
Sell
STOCHRSI (14)
90.37
Sell
MACD (12,26)
0.24
Sell
ADX (14)
23.61
Neutral
Williams %R
-16.71
Sell
CCI (14)
166.24
Sell
ATR (14)
0.57
-
Ultimate Oscillator
65.10
Neutral
ROC
6.71
Buy
Royalty Pharma PLC’s (RPRX) Relative Strength Index (RSI) is 65.97, creating a Neutral signal.
Royalty Pharma PLC’s (RPRX) Trend Strength Indicator (ADX) is 23.61, creating a Neutral signal.
Royalty Pharma PLC’s (RPRX) Commodity Channel Index (CCI) is 166.24, creating a Sell signal.
Royalty Pharma PLC’s (RPRX) Price Rate of Change (ROC) is 6.71, creating a Buy signal.

FAQ

Is RPRX a Buy, Hold, or Sell?
Based on RPRX’s technical indicators, RPRX is a Buy.
    What is RPRX’s RSI (14)?
    RPRX’s RSI (14) is 65.97, which suggests RPRX is a Neutral.
      What is RPRX’s MACD?
      RPRX’s MACD is 0.24, which suggests RPRX is a Sell.
        What is RPRX’s 5-day moving average?
        RPRX’s 5-day moving average is 27.78, which suggests RPRX is a Buy.
          What is RPRX’s 20-day moving average?
          RPRX 20-day moving average is 26.68, which suggests RPRX is a Buy.
            What is RPRX’s 50-day moving average?
            RPRX’s 50-day moving average is 26.99, which suggests RPRX is a Buy.
              What is RPRX’s 200-day moving average?
              RPRX’s 200-day moving average is 27.82, which suggests RPRX is a Buy.
                What is RPRX’s Williams % R (14)?
                RPRX’s Williams % R (14) is -16.71, which suggests RPRX is a Sell.
                  What is RPRX’s CCI (14)?
                  RPRX’s CCI (14) is 166.24, which suggests RPRX is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis